Key Market Indicators
Austrian analgesic medicine sales are expected to reach $84.39 million by 2026. This growth of 0.4% per year on average is an increase from the $83.82 million recorded in 2021. The Austrian market has grown at a rate of 2.9% per year since 2015. This year, Austria is ranked at number 15, with Chile surpassing it at $83.82 million. Spain, Canada, and Italy respectively come in at number two, three, and four.
